EXOZ - eXoZymes, Inc. News

Discover

EXOZ

eXoZymes, Inc.

5.10

1 x 4.85

1 x 5.51

bid

ask

0.23

4.32%

12:00 PM

timesize

Ytd	-53.21%
1y	-44.50%

5.20

day range

5.34

5.10

52 week range

18.40

Open	5.34	Prev Close	5.33	Low	5.20	High	5.34	Mkt Cap	49.42M
Vol	1.52K	Avg Vol	8.33K	EPS	-1.15	P/E	-4.63	Forward P/E	N/A
Beta	2.73	Short Ratio	N/A	Inst. Own	N/A	Dividend	N/A	Div Yield	N/A
Ex Div Date	N/A	Earning	05-12	50-d Avg	8.27	200-d Avg	10.55	1yr Est	0.00

EXOZ News

benzinga.com

eXoZymes Wins $2M NIH Grant To Advance Cannabinoid Analogs For Drug Discovery

Award allows eXoZymes to expand its portfolio of proprietary new-to-nature molecules and potential f

accessnewswire.com

eXoZymes Awarded $2 Million NIH Grant to Advance Cannabinoid Analogs for Drug Discovery

Award allows eXoZymes to expand its portfolio of proprietary new-to-nature molecules and potential f

accessnewswire.com

eXoZymes Inc. Announces Closing of $6 Million Public Offering

LOS ANGELES, CA / ACCESS Newswire / June 17, 2026 / eXoZymes Inc. (NASDAQ:EXOZ) ("eXoZymes" or "Comp

benzinga.com

eXoZymes Prices ~$5.33M Offering Of Units At $18/Unit

eXoZymes Inc. (NASDAQ:EXOZ) ("eXoZymes" or "Company") - a pioneer of AI-enhanced enz

accessnewswire.com

eXoZymes Inc. Announces Pricing of Public Offering of Common Stock and Warrants

LOS ANGELES, CA / ACCESS Newswire / June 8, 2026 / Today, eXoZymes Inc. (NASDAQ:EXOZ) ("eXoZymes" or

accessnewswire.com

eXoZymes Announces Graduation from Shell GameChanger(TM) Accelerator Powered by NLR (GCxN) Program

LOS ANGELES, CA / ACCESS Newswire / May 7, 2026 / Today, eXoZymes Inc. (NASDAQ:EXOZ) ("eXoZymes") -

accessnewswire.com

eXoZymes CCO, Damien Perriman, Outlines NCTx Strategy and the Commercial Path for Cell-Free Biomanuf

LOS ANGELES, CA / ACCESS Newswire / April 10, 2026 / Today, eXoZymes Inc. (NASDAQ:EXOZ) ("eXoZymes")

accessnewswire.com

eXoZymes Provides Fourth Quarter and Full Year 2025 Update

Management to Host Conference Call Today at 5:30 PM Eastern LOS ANGELES, CA / ACCESS Newswire / Marc

benzinga.com

Earnings Scheduled For March 31, 2026

accessnewswire.com

eXoZymes to Host Fourth Quarter and Full Year 2025 Results Conference Call on Tuesday March 31, 2026

LOS ANGELES, CA / ACCESS Newswire / March 25, 2026 / Today, eXoZymes Inc. (NASDAQ:EXOZ) ("eXoZymes")

accessnewswire.com

Successful Pilot Scale Run with Cayman Chemical Validates eXoZymes' Technology and Scalability

LOS ANGELES, CA / ACCESS Newswire / March 18, 2026 / Today, eXoZymes Inc. (NASDAQ:EXOZ) ("eXoZymes")

accessnewswire.com

eXoZymes' CCO Damien Perriman to Present a NCT Solution at Next Week's MISTA Symposium

LOS ANGELES, CA / ACCESS Newswire / March 12, 2026 / Today, eXoZymes Inc. (NASDAQ:EXOZ) ("eXoZymes")

defenseworld.net

Head-To-Head Analysis: eXoZymes (NASDAQ:EXOZ) & Curis (NASDAQ:CRIS)

eXoZymes (NASDAQ: EXOZ - Get Free Report) and Curis (NASDAQ: CRIS - Get Free Report) are both small-

accessnewswire.com

With Refreshed Brand eXoZymes Sharpens Pharmaceutical Focus to Drive Platform Leverage and Long-Term

LOS ANGELES, CALIFORNIA / ACCESS Newswire / February 10, 2026 / Today, eXoZymes Inc. (NASDAQ:EXOZ) (

defenseworld.net

Critical Review: eXoZymes (NASDAQ:EXOZ) vs. Disc Medicine (NASDAQ:IRON)

eXoZymes (NASDAQ: EXOZ - Get Free Report) and Disc Medicine (NASDAQ: IRON - Get Free Report) are bot

accessnewswire.com

eXoZymes Advancing Commercial Readiness With Profound Production Metrics on Initial NCT Pilot Run

N-trans-caffeoyltyramine (NCT) is an interesting naturally occurring compound that has attracted sci

defenseworld.net

eXoZymes (NASDAQ:EXOZ) Stock Price Down 1.7% – Here’s Why

eXoZymes Inc. (NASDAQ: EXOZ - Get Free Report) traded down 1.7% during mid-day trading on Monday. Th

accessnewswire.com

eXoZymes Achieves 100× Scale-up of NCT Production Using Exozymes, Demonstrating Near-perfect Feedsto

LOS ANGELES, CALIFORNIA / ACCESS Newswire / December 11, 2025 / Today, eXoZymes Inc. (NASDAQ:EXOZ) (

accessnewswire.com

eXoZymes Provides Third Quarter 2025 Update at 5PM EST Today

Management to host Q3 2025 update at 5:00PM Eastern Time, today. LOS ANGELES, CALIFORNIA / ACCESS Ne

accessnewswire.com

eXoZymes Announces Cell-Free Biomanufacturing Pioneer, Tyler Korman, As CSO & Amy Lunzer as Chief of

LOS ANGELES, CA / ACCESS Newswire / November 13, 2025 / Today, eXoZymes Inc. (NASDAQ:EXOZ) ("eXoZyme

benzinga.com

Earnings Scheduled For November 13, 2025

accessnewswire.com

eXoZymes to Host Third Quarter 2025 Update on Thursday November 13, 2025, at 5PM EST

LOS ANGELES, CALIFORNIA / ACCESS Newswire / November 10, 2025 / Today, eXoZymes Inc. (NASDAQ:EXOZ) (

benzinga.com

12 Health Care Stocks Moving In Friday's After-Market Session

accessnewswire.com

CEO of eXoZymes on 'AI in Life Sciences' panel at the Beryl Elites' Investment Conference

LOS ANGELES, CALIFORNIA / ACCESS Newswire / October 30, 2025 / Today, eXoZymes Inc. (NASDAQ:EXOZ) ("

accessnewswire.com

CEO of eXoZymes to Present at Spartan Capital Securities' Second Annual Investor Conference

LOS ANGELES, CALIFORNIA / ACCESS Newswire / October 29, 2025 / Today, eXoZymes Inc. (NASDAQ:EXOZ) ("

benzinga.com

Earnings Scheduled For April 2, 2025